Close

Bayer signs agreement to buy animal health business from KMG Chemicals

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

The Best Type of Accreditation for a Telehealth Provider

Telehealth and remote patient monitoring services are becoming more...

Pharmaceutical Contract Sales Market to Hit $26.24B by 2034

Contract Sales Organizations: Transforming Pharma Companies Contract sales organizations –...

What Are the Benefits of Outsourcing to a Clinical Research Organization?

Have you ever wondered if outsourcing certain tasks could...

What’s Missing from Drug Warning Labels? A Look at Patient Safety

Drug warning labels are meant to protect patients. But...

Bayer HealthCare, a subgroup of Bayer AG, has signed an agreement to acquire the animal health business from Texas based KMG Chemicals Inc. for executing its strategy to strengthen animal health portfolio. With a wide variety of innovative, time-tested and proven animal health product lines KMG offers one of the broadest insecticide product lines in the world, including the leading brand of insecticide ear tags for cattle in the United States.

This leading brand insecticide cattle ear tag is supported by a product line consisting of several liquid and dust formulations of insecticides for cattle, swine, poultry and other animals, as well as applications for the premises used to house such animals.

In 2011 the animal health business of KMG had sales of US$ 11.4 million. The transaction will further strengthen Bayer’s existing protective insecticides portfolio, allowing the company to offer a broader range of products.

Products acquired under the agreement with KMG include brands such as the Patriot cattle ear tag and the Rabon and Permectrin products. These products repel insects that can transmit diseases and therby help to preserve the health of lifestock. Bayer plans to explore ways to further develop the insecticides market and continue to bring innovations to this category. Financial terms of the transaction were not disclosed.

KMG is a market leader in producing and supplying high-purity process chemicals, which are an integral part of the semiconductor manufacturing process, and wood treating chemicals used to extend the useful life of the nation’s wood-based infrastructure.

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, is one of the world’s leading, innovative companies in the healthcare and medical products industry.

Latest stories

Related stories

The Best Type of Accreditation for a Telehealth Provider

Telehealth and remote patient monitoring services are becoming more...

Pharmaceutical Contract Sales Market to Hit $26.24B by 2034

Contract Sales Organizations: Transforming Pharma Companies Contract sales organizations –...

What Are the Benefits of Outsourcing to a Clinical Research Organization?

Have you ever wondered if outsourcing certain tasks could...

What’s Missing from Drug Warning Labels? A Look at Patient Safety

Drug warning labels are meant to protect patients. But...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back